Ruppert, A-M <br/><br/>
EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up.  [electronic resource] 

 -  The European respiratory journal  Feb 2009 
 - 436-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1399-3003 
<br/><br/><label>Standard No.: </label>10.1183/09031936.00162307  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--pathology<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Central Nervous System Neoplasms--secondary<br/>Drug Resistance, Neoplasm<br/>ErbB Receptors--antagonists & inhibitors<br/>Erlotinib Hydrochloride<br/>Gefitinib<br/>Humans<br/>Liver Neoplasms--secondary<br/>Lung Neoplasms--pathology<br/>Male<br/>Neoplasm Metastasis<br/>Quinazolines--administration & dosage<br/>Recurrence<br/>Treatment Outcome